These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25333799)

  • 1. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
    Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
    PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.
    Theilacker C; Kaczynski Z; Kropec A; Fabretti F; Sange T; Holst O; Huebner J
    Infect Immun; 2006 Oct; 74(10):5703-12. PubMed ID: 16988246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.
    Kodali S; Vinogradov E; Lin F; Khoury N; Hao L; Pavliak V; Jones CH; Laverde D; Huebner J; Jansen KU; Anderson AS; Donald RG
    J Biol Chem; 2015 Aug; 290(32):19512-26. PubMed ID: 26109072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection.
    Sava IG; Heikens E; Kropec A; Theilacker C; Willems R; Huebner J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1001-1004. PubMed ID: 20522627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.
    Theilacker C; Kaczyński Z; Kropec A; Sava I; Ye L; Bychowska A; Holst O; Huebner J
    PLoS One; 2011 Mar; 6(3):e17839. PubMed ID: 21437253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
    Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
    J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.
    Ali L; Blum HE; Sakιnç T
    Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.
    Sadones O; Kramarska E; Laverde D; Berisio R; Huebner J; Romero-Saavedra F
    BMC Microbiol; 2024 Jul; 24(1):280. PubMed ID: 39068414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
    Huebner J; Wang Y; Krueger WA; Madoff LC; Martirosian G; Boisot S; Goldmann DA; Kasper DL; Tzianabos AO; Pier GB
    Infect Immun; 1999 Mar; 67(3):1213-9. PubMed ID: 10024563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a peptide mimicking Lipoteichoic acid protects mice against Staphylococcus aureus infection.
    Yi XY; Huang ZX; Hou XR; Zhu P; Wang XY; Luo HB; Liu BY
    Vaccine; 2019 Jul; 37(31):4325-4335. PubMed ID: 31230882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.
    Romero-Saavedra F; Laverde D; Budin-Verneuil A; Muller C; Bernay B; Benachour A; Hartke A; Huebner J
    PLoS One; 2015; 10(8):e0136625. PubMed ID: 26322633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections.
    Kropec A; Sava IG; Vonend C; Sakinc T; Grohmann E; Huebner J
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3429-3434. PubMed ID: 21903755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci.
    Kalfopoulou E; Laverde D; Miklic K; Romero-Saavedra F; Malic S; Carboni F; Adamo R; Lenac Rovis T; Jonjic S; Huebner J
    Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
    Chen Q; Dintaman J; Lees A; Sen G; Schwartz D; Shirtliff ME; Park S; Lee JC; Mond JJ; Snapper CM
    Infect Immun; 2013 Jul; 81(7):2554-61. PubMed ID: 23649092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction.
    Hashimoto M; Furuyashiki M; Kaseya R; Fukada Y; Akimaru M; Aoyama K; Okuno T; Tamura T; Kirikae T; Kirikae F; Eiraku N; Morioka H; Fujimoto Y; Fukase K; Takashige K; Moriya Y; Kusumoto S; Suda Y
    Infect Immun; 2007 Apr; 75(4):1926-32. PubMed ID: 17283098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptidoglycan-associated proteins as vaccine candidates for enterococcal infections.
    Romero-Saavedra F; Laverde D; Wobser D; Michaux C; Budin-Verneuil A; Bernay B; Benachour A; Hartke A; Huebner J
    PLoS One; 2014; 9(11):e111880. PubMed ID: 25369230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.
    Cox AD; St Michael F; Aubry A; Cairns CM; Strong PC; Hayes AC; Logan SM
    Glycoconj J; 2013 Dec; 30(9):843-55. PubMed ID: 23974722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.